Section Arrow
INGN.NASDAQ
- Inogen
Quotes are at least 15-min delayed:2025/04/29 23:56 EDT
Last
 7.28
+0.01 (+0.14%)
Day High 
7.33 
Prev. Close
7.27 
1-M High
7.44 
Volume 
148.97K 
Bid
6.8
Ask
7.49
Day Low
7.11 
Open
7.24 
1-M Low
6.4 
Market Cap 
195.47M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.03 
20-SMA 7.04 
50-SMA 7.75 
52-W High 13.3299 
52-W Low 6.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.52/--
Enterprise Value
212.06M
Balance Sheet
Book Value Per Share
6.47
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
335.71M
Operating Revenue Per Share
12.99
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/29 23:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.